Journal
RESPIROLOGY
Volume 16, Issue 4, Pages 598-603Publisher
WILEY-BLACKWELL
DOI: 10.1111/j.1440-1843.2011.01964.x
Keywords
empyema; aetiology; infection; pleural; pneumonia
Categories
Funding
- National Health & Medical Research Council of Australia
- Western Australian Health Department State Health Research Advisory Council
- Sir Charles Gairdner Research Funds
- Raine Medical Research Foundation
- Westcare (Australia)
- Cancer Council of Western Australia
Ask authors/readers for more resources
The incidence of pleural infection continues to rise worldwide. Identifying the causative organism(s) is important to guide antimicrobial therapy. The bacteriology of pleural infection is complex and has changed over time. Recent data suggest that the bacterial causes of empyema are significantly different between adult and paediatric patients, between community-acquired and nosocomial empyemas and can vary among geographical regions of the world. Since the introduction of pneumococcal vaccines, a change has been observed in the distribution of the serotypes of Streptococcus pneumoniae in empyema. These observations have implications on therapy and vaccine strategies. Clinicians need to be aware of the local bacteriology of empyema in order to guide antibiotic treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available